Background: Radiofrequency microneedling (RFM) is a potential treatment for primary hyperhidrosis. However, its efficacy is unclear, and treatment parameters and outcomes vary across studies.
Objective: To understand the effect of RFM on treating primary hyperhidrosis, as measured by changes in the Hyperhidrosis Disease Severity Score (HDSS) before and after treatment, and to clearly define treatment settings most likely to optimize results.
Materials And Methods: A systematic literature search utilizing Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines was conducted across PubMed, EMBASE, MEDLINE, Web of Science, and the Cochrane Library. Studies were evaluated for risk of bias via the ROBINS-I tool and Levels of Evidence/GRADE criteria. A random forest model identified RFM settings that predict HDSS score decrease.
Results: Six publications met inclusion criteria. The level of evidence was classified as Grade B, indicating moderate quality. RFM intervention resulted in a mean HDSS score decrease of 1.63 (52% reduction, p < .05). The strongest predictors for HDSS score decrease were dwell time, energy, and depth, with feature importances of 0.43, 0.19, and 0.15 respectively.
Conclusion: Radiofrequency microneedling treatment significantly reduces HDSS scores in patients with primary hyperhidrosis. Moving forward, it would benefit physicians to standardize objective protocols in reporting RFM parameters and measuring outcomes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/DSS.0000000000004532 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Radiofrequency Microneedling in Treating Primary Hyperhidrosis: A Systematic Review and Meta-Analysis.
Dermatol Surg
January 2025
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Background: Radiofrequency microneedling (RFM) is a potential treatment for primary hyperhidrosis. However, its efficacy is unclear, and treatment parameters and outcomes vary across studies.
Objective: To understand the effect of RFM on treating primary hyperhidrosis, as measured by changes in the Hyperhidrosis Disease Severity Score (HDSS) before and after treatment, and to clearly define treatment settings most likely to optimize results.
Evaluation of Efficacy and Safety of miraDry Procedure in the Treatment of Primary Axillary Hyperhidrosis.
Aesthetic Plast Surg
January 2025
Department of Plastic, Reconstructive and Aesthetic Surgery, Academic Hospital Feldkirch, Carinagasse 47, 6807, Feldkirch, Austria.
Introduction: Primary axillary hyperhidrosis significantly impacts the quality of life of affected individuals. miraDry, a non-invasive local precisely controlled thermal energy procedure, represents a promising treatment option. This retrospective analysis aimed to evaluate the treatment success and patient safety following miraDry procedure in the treatment of primary axillary hyperhidrosis.
View Article and Find Full Text PDFComparing Compensatory Sweating After Video-Assisted Thoracoscopic Sympathectomy: (T2-3) Versus (T2-4) Levels for Treating Palmar Hyperhidrosis.
Cureus
November 2024
Department of Cardiothoracic Surgery, Alexandria University, Alexandria, EGY.
Introduction: Primary hyperhidrosis is a disease that is characterized by excessive sweating beyond what is required to maintain the normal temperature of the body. Moreover, it has a great adverse effect on the life of the affected persons because of problems in their social lives. There are different modalities to treat primary hyperhidrosis, including medical and surgical treatment.
View Article and Find Full Text PDFEfficacy and safety of sofpironium in treatment of primary hyperhidrosis: a systematic review.
J Dermatolog Treat
December 2025
Faculty of Medicine, University of Kalamoon, Al_Nabk, Syria.
Background: Primary axillary hyperhidrosis has limited noninvasive and effective treatment, and we present the use of sofpironium bromide as a promising treatment option. We aimed to assess the efficacy and safety of sofpironium in patients with primary hyperhidrosis.
Methods: We systematically searched the databases for Studies that assessed sofpironium bromide in patients with primary axillary hyperhidrosis.
Continuous evaluation of exosomatic electrodermal activity in patients with primary palmoplantar hyperhidrosis.
Einstein (Sao Paulo)
December 2024
Department of Clinical Analysis, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.
Article Synopsis
- The study aimed to objectively assess sweat intensity in patients with primary hyperhidrosis by measuring their electrodermal activity without external prompts.
- Researchers compared two groups: 10 patients suffering from palmoplantar hyperhidrosis and 10 control individuals, evaluating their sweat perception and mental health through questionnaires and measuring electrodermal activity with a portable device.
- Results showed that patients with hyperhidrosis had significantly higher palmoplantar sweating and skin conductance compared to controls, but no notable differences in anxiety or depression levels between the groups, confirming the effectiveness of the non-invasive measuring technique.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!